Health Condition 1: null- Metastatic breast cancer OR Recurrent ovarian cancer OR Gastric/Gall bladder/Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Metastatic breast cancer who have received at least 2 lines of chemotherapy in metastatic setting and progressed thereafter OR 2. Recurrent ovarian cancer who have received at least 2 lines of chemotherapy for recurrent disease and progressed therafter OR 3. Gastric/Gall bladder/Pancreatic cancer patients who have received at least 1 line of chemotherapy and progressed thereafter
Exclusion criteria
Exclusion criteria: Not willing to consent for participation or not willing to be followed-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To determine the association of overall survival with various clinical, laboratory and pathological factors in patients with advanced metastatic solid cancers. 2. To create a model for predicting survival using significant variables. 3. To use the model to predict survival estimates in an independent validatory set of patients.Timepoint: Patients, satisfying the inclusion criteria and willing to participate in the study, would be recruited and prospectively followed up every 3 months (physically /telephonically) over a period of 24 months from the date of visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| To build a model, using commonly available clinical, pathologic and laboratory variables, to predict survival in patients with advanced solid cancers.Timepoint: 24 months from the date of visit. | — |
Countries
India
Contacts
Public ContactMr Yogesh Kembhavi
Tata Memorial Centre
Outcome results
None listed